| Characteristics | Surgical repair | Outcome |
|---|
| Author | Median ISS (range) | TAWDs | Total (%) | Acute | Delayed | Mesh | Recurrence rate (mesh used) | Mortality (%) | Loss to FU (%) |
|---|
| Park | nm | 9 | 8 (89) | 0 | 7 | 7 | 0 | 0 | 0 |
| Pardhan | 23 (nm) | 44 | 41 (93) | 8 | 33 | 5 | 3 (0) | 4 (9) | 1 (2) |
| Coleman | 22 (nm) | 80 | 23 (29) | 18 | 5 | 7 | 6 (3) | 0 | nm |
| Honaker | 17 (1–66) | 38 | 30 (79) | 27 | 3 | 11 | 3 (2) | 2 (5) | 0 |
| Bender | 35 (nm) | 25 | 22 (88) | 11 | 11 | 18* | 3 (1) | 1 (4) | 3 (12) |
| Netto | 31 (18–44) | 34 | 10 (29) | 8 | 2** | 1 | 3 (0) | 1 (3) | 11 (32) |
| Vijayalakshmi | nm | 4 | 4 (100) | 4 | 0 | 0 | 0 | 0 | 0 |
| Akbaba | nm | 3 | 2 (33) | 0 | 2 | 2 | 0 | 0 | 0 |
| Guttenridge | 14 (9–29) | 5 | 4 (80) | 3 | 1 | 2 | 0 | 0 | 1 (20) |
| Singal | nm | 3 | 3 (100) | 3 | 0 | 1 | 0 | 0 | 0 |
| Agarwal | nm | 2 | 2 (100) | 2 | 0 | 1 | 0 | 0 | 0 |
| Kumar | nm | 2 | 2 (100) | 2 | 0 | 0 | 0 | 0 | 0 |
| Burt | nm | 3 | 3 (100) | 0 | 3 | 3 | 1 (1) | 0 | nm |
| Brenneman | nm (mean 25) | 9 | 7 (78) | 2 | 5 | 5 | 2 (0) | nm | nm |
| Damschen | nm | 4 | 2 (50) | 2 | 0 | 0 | 1 (0) | nm | 2 (50) |
| Fullerton | nm | 2 | 2 (100) | 2 | 0 | nm | 0 | 1 (50) | nm |
| Guly | nm | 2 | 2 (100) | 1 | 1 | 0 | 0 | 0 | 0 |
| Danto | nm | 3 | 3 (100) | 3 | 0 | nm | nm | 1 (33) | nm |
| Payne | nm | 2 | 2 (100) | 1 | 1 | 0 | 1 (0) | 0 | nm |
| Total | NA | 274 | 172 (63) | 98 | 74 | 63 | 23 (7) | 10 (NA) | 18 (NA) |
- This table shows surgical repair and outcome for all 19 studies. From a total of 274 patients with TAWDs, 172 underwent surgical repair, both acute (n = 98) and delayed (n = 74), with a minority of mesh repair (n = 63). A total of 23 recurrences occurred in this patient group
- nm not mentioned, NA not applicable
- *Reinforcement consists of absorbable mesh, permanent mesh, and acellular cadaver dermis
- **Two of the patients who were initially treated conservatively developed symptoms requiring surgery after 8 months
